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ABSTRACT 
Currently iontophoresis is used by many physical 
therapists on a variety of pathological conditions. 
Therefore, therapists must have a thorough understanding of 
this modality as to provide the best, most efficient care 
possible to our patients. 
The purpose of this study is to provide clinicians with 
a review of the available literature on iontophoresis in 
physical therapy. The history and principles of 
iontophoresis are briefly discussed, followed by a review of 
the clinically performed studies. This section includes 
studies related to pain and range of motion, tissue repair, 
movement of fluids, and other diagnoses. Animal and in vitro 
experimental studies will accompany many of the clinical 
studies. 
Many of the studies reviewed demonstrated relatively 
favorable results, but some of these were conducted in a non 
scientific manner. The decision to use iontophoresis must be 
made on an individual basis, and the therapist should make 
this decision only after reviewing the available literature 






Iontophoresis has had many names throughout history, 
including; iontransfer,l iontherapy, ion medication, 
galvanoionization, and medical ionization. 2 These similar 
terms all have a common meaning being the propulsion of ions 
through a membrane with the use of electricity. 
In 1747, Veratti used iontophoresis to drive lons into 
tissue, and this may be the first documented use of 
iontophoresis as we know it today. 2,3 The inception of 
iontophoresis for medical purposes came about with the work 
of Leduc in the early 1900' s. 4,5 This involved the 
iontophoresis of strychnine into rabbits ears causing them 
to die a few minutes after the current was initiate. 
The equipment used for iontophoresis has changed 
throughout history. In 1939, a study on the iontophoresis of 
copper into the hands and feet of subjects, utilized four 
pans of water and copper electrodes. 6 The original power 
source in this study was a battery to which a rheostat was 
connected. The authors indicated that there was potential 
for shocking the subject based on the make-break phenomenon. 
Eventually they constructed a device in which 110 volt 
1 
2 
current was rectified to direct current. A . similar battery 
power source was used by Rapperport et a1 7 in 1965. The 
electrodes in this study were assembled using gauze 
saturated with aqueous solution of the chosen drug, lead 
electrodes, and connection alligator clips. 
Today the power sources range from the typical line-
operated DC generator to a battery powered, computerized, 
programmable device. 1,2 Depending on the physiological 
effects desired and drug chosen, some electrode 
configurations continue to use the gauze and tin foil 
electrodes8 similar to that used by Rapperport. 7 Many of the 
current systems and common drugs can be applied utilizing 
patch electrodes with a self-containing pouch for the drug. 9 
PRINCIPLES OF IONTOPHORESIS 
In the most simple terms, iontophoresis is defined as 
driving specifically charged ions through the skin by the 
use of a specific electrical charge. 5,10 Ions are charged 
particles and like charges repel. 1 Therefore if a drug is 
placed between the skin and the active electrode of the same 
charge, using DC galvanic current, the ions will be driven 
into the tissue below. The attraction of the ions towards 
the dispersive electrode (opposite charge) is insignificant 
ln the iontophoresis process according to Barry.10 
Studies show evidence that the most probable avenue for 
lon transfer is by way of the sweat glands. 2,11,12 However, 
the specific mechanism of transfer for some drugs has not 
3 
been established. 13 
Historically, continuous galvanic current has been the 
current of choice in iontophoresis. 1,8,14 Bagniefski and 
Burnette15 compared pulsed and continuous currents in the 
iontophoresis of Na ions on excised mouse skin. They 
observed no significant difference in the ion transfer 
between pulsed or continuous galvanic current. Pikal and 
Shah14 found similar results showing a slight decrease in 
ion transfer with pulsed current. An in vitro study by 
Thysman et al15 concluded that continuous DC current was 
more efficient than pulsed. As the duty-cycle or pulsed 
current was decreased, the ion transfer also decreased. 
DOSAGE 
The quantity of lons delivered to the tissue for 
therapeutic purposes will depend on three factors: 8 
1) Current density under the active electrode where higher 
density increases ion transport, 2) Time which current is 
allowed to flow,2 and 3) Concentration of ions in the 
solution. A low concentration of ions is recommended for 
iontophoresis. 1 ,16 A formula using the specific electro-
chemical equivalency (ECE) is used to determine amounts of 
ion transfer. 1 Intensity (amperes) X Time (hours) X ECE = 
grams of ion transferred. 
PURPOSE 
Currently iontophoresis is used by many physical 
therapists on a variety of pathological conditions. Third-
4 
party payers, physicians, and patients are beginning to 
demand proof that treatments are effective and efficient. 
Therefore, therapists must have a thorough understanding of 
this modality and which treatments are or are not supported 
by research. The purpose of this study is to provide 
clinicians with a review of the available literature on 
iontophoresis used in physical therapy. 
CHAPTER 2 
CLINICAL STUDIES: LITERATURE REVIEW 
PAIN AND RANGE OF MOTION 
Many disorders have pain, inflammation, and/or muscle 
spasms as signs and symptoms. A complex cycle can form among 
the symptoms with pain causing inflammation and/or muscle 
spasms. Each of these can cause an increase in symptoms and 
ultimately a spiraling cycle is formed. 17 As the cycle 
continues, function in the involved area diminishes. 
Range of motion (ROM) is one of the early functions to 
be limited. Although ROM is not directly affected by the 
iontophoretic delivery of specific substances, it can be 
altered through reductions in pain. The goal of 
iontophoresis is to utilize a specific drug, depending on 
its pharmacological effect, to break the pain cycle and 
restore the patient to the highest level of function 
possible. 
Dexamethasone sodium phosphate (DSP) lS a commonly 
utilized analgesic drug used in iontophoresis. 18 A study by 
Glass et al19 found measurable amounts of DSP could transfer 
down to and including tendinous and c~rtilaginous tissue 
though the use of iontophoresis. DSP and lidocaine 
5 
6 
hydrochloride are two substances frequently used in 
combination during iontophoresis. 20 The lidocaine has an 
analgesic effect, while DSP is used in many inflammatory 
conditions. 
Petelenz and associates21 researched the delivery of 
DSP combined with lidocaine in in V1VO and in vitro studies. 
The in vitro studies demonstrated that significant amounts 
of DSP were delivered when the two drugs were combined, but 
the amount delivered nearly doubled when DSP was phoresed as 
an isolated substance. In vivo studies provided no 
significant differences, between positive versus negative 
electrode, in the amount of DSP delivered. A study by 
Chantraine et a1 22 is not in support of this research, and 
failed to provide evidence of the delivery of various 
steroids including DSP. 
Bertolucci23 implemented a study to determine the 
effects of DSP on pain and range-of-motion (ROM) . Fifty-
three subjects were utilize. Diagnoses included: 
infraspinatus and supraspinatus tendinitis; adhesive 
capsulitis of the shoulder; bicipital tendinitis; lateral 
epicondylitis; and sacroiliitis . Subjects were randomly 
assigned to a experimental group or a control group. The 
experimental group received four treatments of 4 mg/ml DSP 
combined with 2 cubic cm of lidocaine hydrochloride at 65 
rnA-min each. Pain levels were assessed on day 1 and 3. The 
age group which indicated the highest incidence of excellent 
7 
benefits was the 18 to 34 year old group. The thirty-five to 
44 year old group indicated significant pain reduction while 
only 41% of the subjects in the >45 age group received any 
relief from treatment. As the subjects pain decreased their 
ROM increased. 
weinstein and Gordon24 studied the effects of 
iontophoresis on subdeltoid bursitis based on a chart review 
of 50 randomly selected patients. Treatment involved 
iontophoresis of a 2% solution of magnesium sulphate at 10-
20 rnA-min. This was the only treatment administered. In 68% 
of these cases all signs and symptoms were alleviated and 
full ROM was recovered. 
Treatment of trigger areas in shoulder girdle 
myofascial syndrome was studied by Delacerda. 25 The study 
compared the treatment of DSP iontophoresis with a group 
that received muscle relaxants and pain medication and one 
that received hot packs and ultrasound. Although all 
subjects experienced some pain relief, the iontophoresis 
group experienced complete pain relief after day nine. 
A study by Harris 9 examined the effects of 
iontophoresis on individuals with inflammatory conditions 
consisting of tendinitis, bursitis, ligamentous sprains, and 
epicondylitis. Fifty subjects received one to three 
treatments consisting of 80 rnA-min. The utilized drug was 1 
cc of 4 mg dexadron and 2 cc of 4% xylocaine. Evaluation of 
treatment effectiveness was based on active range-of-motion 
8 
(AROM)! pain! edema! temperature! and function. The results 
indicated that: 75% of the patients had good to excellent 
results; 14% had significant decreased pain and increased 
strength and ROM; and 11% had little to no decreased pain. 
Delacerda26 found immediate but short-term pain relief from 
2.5% xylocaine iontophoresis. Although the focus of a study 
by Psaki and Carrol127 was on calcium absorption! they found 
favorable results in pain reduction and increased ROM. 
Individuals with temporomandibular joint (TMJ) 
disorders can have secondary symptoms including pain! 
inflammation! muscle spasms! and decreased ROM. 17 ,28 Lark and 
Gangarosa29 describe a protocol for the iontophoresis of DSP 
in the treatment of individuals with TMJ disorders. Braun28 
describes the use and results of the iontophoretic delivery 
of 1 cc DSP and 2 cc lidocaine hydrochloride (4%) in the 
treatment of TMJ pathology. In this case study! the patient 
received two 80 rnA-min treatments with one day separating 
the treatments. The patient also performed a home exercise 
program consisting of AROM! stretching! and rhythmic 
stabilization exercises. Decreases in pain along with 
increases in ROM were reported after the initial treatment 
and continued this progression throughout treatment. Results 
similar to these were reported by Lark and Gangarosa29 in 
several case studies. 
A case study by Kahn30 focused on paln and decreased 
ROM of the TMJ in a subject following minor surgery for 
9 
infected maxillary sinuses. The subject reported complete 
TMJ pain relief after the second treatment of 100 rnA-min 
iontophoresis of hydrocortisone ointment followed by three 
minutes of ultrasound. ROM was also increased throughout 
treatment. Similar relief in pain with hydrocortisone 
iontophoresis was reported by Paski et al. 31 but findings by 
other researchers were not as supporting. 19,22 
The purpose of a study by Paski et al 31 was to 
determine the effectiveness of hydrocortisone iontophoresis 
on subjects with rheumatoid arthritis (RA) and 
osteoarthritis (OA). One-hundred white males between the 
ages of 25 and 65 years old were selected as sUbjects. 
Thirty subjects were diagnosed with RA and the remainder had 
OA. Pain and ROM were assessed at the onset of the study 
then weekly for three months. Skin condition and x-ray 
results were assessed where applicable. Treatment areas 
included the hand, wrists, elbows, shoulders, knees, ankle, 
foot, toes, and back. Chronic cases received treatment 
biweekly for at least six weeks and acute cases three times 
per week for at least SlX weeks. Each area in question 
received infrared heat prior to and during treatment. 
Hydrocortisone ointment was massaged into the effected area 
and current was applied. Subjects with back involvement 
received 300 rnA-min of iontophoresis while the remainder of 
the subjects received 60-150 rnA-min depending on current 
tolerated by each subject. 
10 
Of the subjects with RA, 90% had pain relief and ROM 
was restored fully in 50%, but some subjects experienced 
increased pain initially followed by decreased pain. In 50% 
of the subjects with OA, pain relented entirely and the 
remaining cases demonstrated pain reduction. ROM was also 
fully recovered in 50% of the sUbjects. 
In a study utilizing citrate iontophoresis, Coyer32 
demonstrated only temporary pain relief. Thirty-five 
subjects with the diagnosis of and acute exacerbation of RA 
were assigned to three groups. Group 1 received 200-300 mA-
min of iontophoresis ih a bath containing 2% solution of 
potassium citrate and distilled water. Group 2 and 3 were 
both control groups, and received tap water iontophoresis 
with either negative or positive charge at an average of 20 
mAo The treatment time was not indicated for group 2 or 3. 
Treatment was administered every other day for four weeks. 
Subjective reports of significant pain relief were 
conveyed by 86% of the experimental group, but this effect 
wore off throughout the immediate day. Of the control 
groups, 90% experienced no pain reduction, while 30% 
indicated increased pain and swelling. On the average, grip 
strength improved in the citrate iontophoresis group but not 
in either control group. 
Kahn33 used iontophoresis of lithium in a subject with 
gouty arthritis. He demonstrated immediate short term relief 
of pain and long term relief after four weekly treatments. 
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The lithium was transferred at a dosage of 100 rnA-min. 
Salicylate iontophoresis was found to be effective ln 
eliminating prolonged muscle pain post-surgery.34 Nearly two 
months post total hip replacement, the subject developed 
pain in her rectus femoris. Numerous treatments, including 
chloride iontophoresis and mecholyl iontophoresis, were 
attempted with minimal success. After three treatments of 
salicylate iontophoresis, at 80 rnA-min, the subject reported 
significant pain relief. Two months later, thigh pain 
returned, but it was eradicated following one salicylate 
iontophoreses treatment. A one year follow up on this 
subject indicate no return of thigh pain. 
Singh and Roberts 35 have demonstrated the depth of 
penetration of salicylic acid to be only 3-4 mm. The 
concentration of salicylic acid at depths >3-4 mm is not 
significantly greater with iontophoresis than with passive 
transportation. 
Delacerda26 utilized 12 subjects with shinsplints, SlX 
of which had bilateral cases, for a total of 18 cases of 
shinsplints. The subjects rated their pain as mild, 
moderate, or severe. During each treatment the subject 
received 100 rnA-min of iontophoresis at 48 hour intervals. A 
limit was set at a maximum of ten treatments. Complete pain 
relief was experienced by a group that initially received 
xylocaine iontophoresis (2.5%). Since pain returned prior to 
subsequent treatment, the xylocaine treatment was 
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discontinued after the third treatment and replaced with 
hydrocortisone (0.5%) for the remainder of the study. One to 
six (average 3.05) treatments were required to eliminate 
pain in all of the cases of shinsplints. 
Although acute pain may be beneficial, chronic pain 
linked to neuralgic and neuralgiform pain syndromes appears 
to serve no real purpose. 36 This type of pain is connected 
with diagnoses such as: post-discotomie syndrome37 which can 
occur following surgical procedures involving the 
intervertebral disk; post-herpetic neuralgia;38 terminal 
pain,39 metabolic polyneuropathy, and trigeminal neuralgia. 
The remainder of this section on pain will focus on the 
use of vinca alkaloid iontophoresis treatment of subjects 
with various types of chronic pain secondary to peripheral 
nerve lesions. The premise behind this treatment is that the 
vinca alkaloids possess the ability to block the retrograde 
transmission within the peripheral nervous system. 37 ,39 
Research by Knyihar-Csillik et a1 40 supports the 
physiological and ionic transport mechanisms of these 
procedures. 
Csillik and associates39 studied the e£fects of vinca 
alkaloids on subjects with chronic pain secondary to various 
diagnoses ranging from intercostal neuralgia to terminal 
pain (11 different diagnoses). Fifty-one subjects received 
daily vinblastine (0.01%) or vincristine (0.001%) 
iontophoresis for eight to 24 days. Subjects each initially 
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received placebo treatment for seven to 14 days followed by 
vinca alkaloid iontophoresis. Diagnoses of the limbs and 
trunk received 600-1800 rnA-min of treatment while areas 
involving the head received 120-300 rnA-min. Subjects rated 
their pain on a scale of <0-0-100 with 100 being total 
elimination of pain, 0 being no change in pain, and a 
negative number indicating increased pain. The subjects 
received no pain relief from placebo treatment. At a one 
year follow-up, 78% of the subjects had experienced no 
return of pain, 16% had partial or temporary alleviation of 
pain, while 6% had felt no decrease in pain. 
Long term pain relief was demonstrated by Knyihar-
Csillik and colleagues. 4o Subjects (n=48) with approximately 
20 different diagnoses and resulting chronic pain were 
treated with vinca alkaloid iontophoresis. At a one year 
follow up, continuance of pain relief ranged from 0-100% 
(mode 100%; mean 91%) with 17% of the subjects experiencing 
some type of relapse during that one year period. The 
poorest results and highest rate of relapse were experienced 
by subjects with trigeminal neuralgia (n=15). 
In the study by Csillik et al,39 pain relief 
experienced by post-surgical subjects with discopathy was 
100% one year post treatment. Penickova and associates37 
reported conflicting results. They37 used 16 post-
discectomy subjects with chronic (5-16 years) nerve root 
pain, and 20 subjects with chronic nerve root pain in the 
14 
dermatomal regions. Numerous conservative and pharmaceutical 
approaches had failed to provide any measure of long-term 
relief. Initially a 0.01% solution of vinblastine was used, 
but this was changed to a protective anode solution allowing 
for a maximum of 50 ml of 0.01% vinblastine solution. 
Subjects each received 150-450 rnA-min of iontophoresis three 
to five times per week until a total of ten treatments had 
been administered. 
The measures of treatment effect were based on a paln 
scale (0-5), a scale rating the effect of pain on ADL's 
(0-5), and a modified McGill Pain Questionnaire. These three 
categories were assessed to obtain overall treatment 
effectiveness (0-5). Mean results from Student's t-tests are 
as follows: no improvement 0%; negligible improvement < 9%; 
slight improvement 10%-24%; medium improvement 25%-45%; and 
considerable improvement> 50%. Although short-term relief 
was experienced, only one post-discectomy subject had 
continued relief lasting longer than six months in duration. 
Sixty-three percent of the subjects had relief for less than 
three months. The 150-450 rnA-min treatment, used in this 
study compared to Csillik's39 600-1800 rnA-min treatment, may 
have been the confounding variable which may explain the 
differences in long-term results. 
A single blind study was carried out by Layman and 
copartners 41 using subjects diagnosed with post-herpetic 
neuralgia. The pain in all of the subjects (n=20) had 
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previously been unresponsive to treatments which included 
TEN's, opiate analgesics, antidepressants, and subcutaneous 
infiltration of lignocaine or hydrocortisone. 
A solution containing 0.01% vincristine, 0.9% saline, 
and 5% dimethyl sulfoxide was delivered to the experimental 
group (n=10) while a control group received only saline 
iontophoresis. Subjects received treatment three times per 
week for a total of 12 treatments at 900-1800 rnA-min 
(dependant on subject tolerance). Subjects completed a 
three-point ordinal pain scale and a visual analogue pain 
scale (VAS) prior to each treatment and at a six week follow 
up. 
At the close of treatment, 80% of the experimental 
group showed improvements on the VAS (mean improvement 59%, 
P<0 . 05) compared to 10% showing improvement in the control 
group. At six weeks, 60% of the experimental group showed 
improvements on VAS (mean improvement 27%, P<0.05). 
Comparable pain relief was demonstrated by Tajti et 
a1 38 when they evaluated 35 cases of subjects who had been 
treated with iontophoresis for post-herpetic neuralgia. 
Percentage of pain relief ranged from 28% to 100% (mean 
54%). Because these were case studies, treatment parameters 
varied and are as follows: 1% vincristine was combined with 
1% hyaluronidase then mixed with distilled water (30ug 
vincristine per cm2 of surface tissue); 60-300 rnA-min 
treatments for areas of the head and neck; 600-1800 rnA-min 
16 
treatments for the limbs and trunk; each subject receive ten 
to 30 treatments. These current-time parameters were very 
similar to those used by Csillik and associates. 39 
Delacerda25 researched the use of iontophoresis for the 
treatment of myofascial syndrome. The subjects (n=23) job 
tasks required them to hold their arm abducted to at least 
70° for approximately 15 seconds at a time. Each of the 
subjects developed what was diagnosed as shoulder girdle 
myofascial syndrome. Seven subjects received pharmaceutical 
treatment, eight received hot packs followed by ultrasound, 
and eight received iontophoresis of 1 cc DSP (0.4%) combined 
with 2 cc lidocaine hydrochloride. The iontophoresis was 
delivered at 85 rnA-min for 10 days or to elimination of 
pain, which ever came first. The subjects who received 
medication continued to have ROM deficits on day 10 along 
with two from the ultrasound group. By day 9, all of the 
subjects from the iontophoresis group had full pain-free 
ROM. 
Another potential cause of reduced ROM can be calcium 
deposits which may occur in untreated tendinitis or deposits 
which form within the muscle itself. If tendinitis is not 
treated, calcium deposits can form as a result of decreased 
blood supply to the effected area. 27 
Absorption of the deposits through acetic acid 
iontophoresis was the focus of a study by Psaki and 
Carroll.27 Each of 12 subjects received iontophoresis of a 
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3% acetic acid solution for 150-300 rnA-min. When the 
subjects could raise their arm with minimal assistance, 
exercises were initiated. 27 The authors concluded the 
following; 1) Calcium deposits were decreased by hyperemia 
and hyperacidity in 40% of the cases, as this was identified 
through pre and post-treatment x-ray findings, 2) Joint pain 
and tenderness disappeared after acetic acid iontophoresis, 
and 3) ROM may be completely restored following 
iontophoreses of acetic acid. 
Results comparable to these were reported in a case 
study by Wieder. 42 In a patient with myositis ossificans of 
the quadriceps femoris muscle, Wieder42 reported a 98.9% 
reduction in the calcified mass and the return of full knee 
ROM following treatment. The iontophoresis consisted of 3 ml 
acetic acid (2%) for 80 rnA-min followed by eight minutes of 
pulsed ultrasound and passive ROM. Treatment continued three 
times per week for three weeks. 
Popkin36 performed two case studies to determine the 
effect of hyaluronidase iontophoresis on scleroderma. 
Scleroderma is a progressive, systemic syndrome 
characterized by hardening and thickening of the skin and 
ultimately decreased ROM. Hyaluronidase hydrolyses 
hyaluronic acid36 is a substance which plays a part in the 
arrangement of the collagen matrix. Popkin36 performed two 
case studies to determine the effect of hyaluronidase 
iontophoresis on scleroderma. In both of the studies he 
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found that during treatment signs and symptoms were 
diminished and the subjects perceived substantial benefits 
including increased ROM. The benefits were determined to be 
only short-term. 
The iontophoresis of iodine ion was used by Langley43 
to treat tendon adhesions, and Tannenbaum44 in reducing 
post-surgical scar tissue. Both case studies utilized an 
Iodex ointment at and 80 and 100 rnA-min of treatment 
respectively. After five consecutive daily treatments, 
Tannenbaum44 found the return of normal ROM and an increase 
in muscle strength from trace to good. At a six month 
follow-up both ROM and strength were normal. Langley43 found 
similar results after three daily treatments. These two case 
studies demonstrate the possibility of scar reduction 
through the use of iontophoresis. 
TISSUE REPAIR 
The physiological basis and the value of zinc ions in 
tissue repair has been discussed by various researchers. 4,45 
When zinc is introduced into the tissue, insoluble 
precipitates are formed with tissue components, and this 
aids in the epithelialization of granular tissue. 45 Zinc ion 
is also considered to be antibacterial. 
Cornwal146 investigated the clinical effectiveness of 
zinc iontophoresis in healing ischemic ulcers. The subject 
had bilateral ulcers secondary to BK amputations. In this 
case study, zinc-oxide ointment (0.1 mole solution) was 
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applied proximal to the lesion and transferred into the 
underlying tissue with approximately 68 rnA-min iontophoresis 
b.i.d. for 20 days. The author demonstrated >98% closure of 
both ulcers at the end of the 20 day period. 
Abramson and associates 47 studied the effects of 
histamine iontophoresis on 14 subjects with various ulcers. 
The affected extremity was placed in a solution (0.0001%) of 
histamine diphosphate, and iontophoresis was administered at 
60 rnA-min two to three times per week. Complete healing of 
trophic changes occurred in four of the subjects with 
progressive systemic sclerosis (n=5), while the fifth 
subject showed some improvements. Subjects with sickle cell 
anemia (n=4), neurotrophic ulcers (n=l), and venous stasis 
ulcers (n=l) all demonstrated improvements, while those with 
ischemic ulcers secondary to arteriosclerosis (n=3) showed 
no improvements. 
Recurrent herpes labialis (RHL) are lesions caused by 
herpes simplex virus (HSV) .48 If left untreated, HSV can 
lead to blindness, encephalitis, and cancer. Healing of the 
lesions usually requires seven to ten days which allows the 
lesions to transmit to other areas of the body or to other 
individuals through venereal contact. Burning, itching and 
severe scabbing generally accompanies healing. 
Gangarosa et a1 48 performed a study which produced 20 
separate trials, six control (C) and 14 experimental (E), 
from six subjects. The C group (non-blind) received no 
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treatment while the E group received 3-5 rnA-min of 
idoxuridine solution (0.1%). Treatment duration was until 
healing was complete usually within 3.4 days (+-0.3) for E 
compared to 8.8 days (+-1.1) for C group. The lesions in the 
E group also healed with less discomfort and scabbing. 
MacCullum and Jensen49 reported a comparable average of 8.9 
days for healing in treatment by topical idoxuridine 
ointment without the assistance of iontophoresis. Gangarosa 
and associates5o feel the reason that topical ointments are 
unsuccessful is not due to drug ineffectiveness, but 
secondary to lack of ion transfer without the assistance of 
iontophoresis. 
Herpetic whitlow is another type of lesion generally 
caused from HSV . 51 The lesions occur on the fingers which 
provide for an easy method of transmission to additional 
body regions or other individuals. Gangarosa and collages51 
reported on two case studies involving the iontophoresis of 
idoxuridine (0.1%) in two subjects with herpetic whitlow. 
Each lesion was treated with at least 0.5 rnA of current for 
ten minutes, and larger lesions received proportionately 
increased dosages. One subject exhibited a 60% decrease in 
healing time and an 80% reduction in severity. This subject 
experience no return of the lesions at 38 months post-
treatment. A second subject experience decreased pain, 
resolved HSV lesions, and lacked recurrent lesions at 48 
months post-treatment. 
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Twenty-seven subjects diagnosed with RHL of the oral 
region participated in a double blind, placebo controlled 
study conducted by Gangarosa and associates. 5o The study 
utilized one control group (C) and two experimental groups 
(E1,E2 ). E1 received iontophoresis of vidarabine 
monophosphate (5.2% solution), E2 received acyclovir (3.5% 
solution), and C received NaCI (0.9%) solution. These 
concentrations allowed for an equal number of ions per ml of 
solution . Current-time settings were at 4.0 rnA-min for all 
subjects, and a total of eight treatments were administered 
over a three week period. The E1 group had significantly 
lower (P<0 . 05) titers of the virus than either E2 or C 
after a 24 hour period, but the number of healing days was 
not significantly different. The authors suggested that a 
single treatment with vidarabine monophosphate may be 
sufficient to offer significant benefits. 
The purpose of three case studies by LaForest and 
Cofrancesco 52 was to study the treatment of burned ears with 
gentamicin sulphate iontophoresis. Two subjects (Sl & S2) 
were positioned in sideling with the burned ear immersed in 
a gentamicin sulphate solution (5mg/ml water) at 5-10 and 35 
rnA-min respectively. One subject (S3) received gentamicin 
sulphate (8mg/ml water) iontophoresis at a dosage of 75 rnA-
min. S3 used a solution soaked gauze pad electrode for ion 
transfer. Sl experienced epithelialization after 12 
treatments/7 days, and had no recurrence at 27 months. 
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Epithelialization for S2 occurred after 24 treatments/13 
days and the subject suffered no recurrence at 8 months. The 
ear of the final subject, S3 had healed following 28 
treatments over a 15 day period. This subject experienced no 
recurrence at 18 months post-treatment . Sela and 
associates53 propose molding a prosthetic device for the ear 
to eliminated the need for ear immersion during 
iontophoresis. 
The transfer of antibiotic ions is supported by 
Rapperport et al. 7 In a double blind study, they 
demonstrated significant (P<O.Ol) levels of penetration of 
penicillin through burn eschar. This research involved 
studies of both human and animal sUbjects. 
The purpose of a study by Haggard et a1 6 was to 
determine the effect of copper iontophoresis on fungal 
infections of the hands and feet. Iontophoresis was 
administered to 37 subjects who had been diagnosed with 
dermatophytosis. Each subject received treatment two or 
three times per week at a dosage of 80-120 rnA-min if one 
extremity was treated or 160-200 rnA-min if both extremities 
were treated simultaneously. If the hands were infected they 
were place in a 0.2% copper sulfate solution with the active 
electrode while the feet were place in a saline solution 
with the dispersive electrode. This arrangement was reversed 
if the feet were infected, and if both were infected the 
subject received two 20 minute treatments. Seventy percent 
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of the subjects obtained a clinical cure after an average of 
six treatments. Eighty-eight percent of these subjects ere 
followed for a period of three to six months, with 22% 
suffering some type of recurrence. 
Jersild and Plesner54 followed-up 35 subjects who had 
received copper iontophoresis (0.001% solution) in the 
treatment of epidermophytia of the hands and feet. 
Iontophoresis was administered at 100-300 rnA-min every other 
day for a total of two to five treatments (85%) or six to 11 
treatments (15%). Of these 35 subjects, 87.5% had 
experienced no reappearance of the epidermophytia. 
It has been demonstrated that silver ions are effective 
bactericidal agents. 55,56 Becker and Spadaro 55 studied the 
effects of silver ion on chronic osteomyelitis with non-
union of the bone. Prior to iontophoresis, surgical 
debridement was used to remove necrotic tissue and drain 
infection. Two separate treatment protocols were used. One 
of the protocols consisted of a pure silver wire electrode 
that was implanted into the bone if wounds could be 
surgically closed. These subjects received continuous 
iontophoresis at 1 microampere per centimeter of exposed 
wire for the first 24 hours. The dosage was then reduced to 
100 nanoampers. This dosage was maintained for approximately 
six weeks until 1.5 to 2.5 joules of total energy were 
delivered. An alternate protocol was used when the wound was 
required to be left open. This involved using a silver 
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impregnated nylon fabric as the electrode. This nylon 
material was packed into the wound site and wrapped with a 
sterile dressing. Current was regulated at 0.9 volts . 
Control of the infection was achieved in 12 out of 15 
treatments. Healing of non-unions also occurred in these 12 
subjects after a period of 3-36 months. Control of the 
infection was not complete in the remaining three 
treatments. 
Satyanand and associates56 used procedures very similar 
to the first treatment technique used by Becker and 
Sparado. 55 Out of the 50 subjects treated, 22 experienced 
good outcomes, 18 fair, and ten poor. The best results were 
experienced by those with Staphylococcus infections (38%), 
and the poorest results by subjects with Proteus infections 
(14%) . 
The silver impregnated fabric method of ion transfer is 
supported by Falcone et al. 57 They demonstrated 
significantly larger inhibitory zones when the silver 
iontophoresis was versus control groups. 
MOVEMENT OF FLUIDS 
Iontophoresis may be used to effect fluid flow in an 
attempt to: 1) Control edema; 2) Increase blood flow and 
nutrients to an injured area; or 3) In some cases, such as 
hyperhidrosis, the clinician wants to decrease the flow of 
fluids. 
The purpose of a study by Schwartz 58 was to determine 
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the effectiveness of hyaluronidase by iontophoresis in 
treating lymphedema. Hyaluronidase decreases the viscosity 
of fluids allowing them to move freely within the 
circulatory system. The subjects (n=5) extremity was wrapped 
in a cloth containing hyaluronidase dissolved in an acetate 
buffer solution. Control iontophoresis treatments (inert 
buffer solution) were randomly substituted for the 
hyaluronidase treatments throughout the study. Each subject 
received 400-600 rnA-min of iontophoresis. Volumetric 
measurements were taken pre and post treatment. Results 
indicate that the treatment was effective, but carryover 
between treatment required the use of an elastic compression 
wrap over the effected extremity. The control treatments 
(mean=4.8) had and 18.4 cc mean reduction in volume compared 
to the hyaluronidase treatment (mean=20.6) which had a 224.1 
cc mean reduction in volume. 
Kahn33 demonstrated elimination of soft tissue edema 
after four treatments in a single case study involving a 
subject with gouty arthritis. The iontophoresis consisted of 
a 2% solution of lithium chloride delivered at 100 rna-min 
per treatment. 
Kovacs et a1 59 have established that Acetyl-B-Methyl-
Choline (ABMC) is a strong vasodilator. Macht and 
associates 60 studied the effectiveness of ABMC (0.2%) 
iontophoresis on blood flow. A total of 31 separate 
experiments were performed on six sUbjects. Blood flow was 
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measured using a venous occlusion fluid-air plethysmograph. 
The subjects initially rested in a temperature controlled 
experiment room for one hour. The hand was then placed in 
the temperature controlled ABMC bath for 30 minutes, after 
which a baseline blood flow measurement was taken. 
Iontophoresis was then carried out at 300-540 rnA-min with 
blood flow measurements taken at five to ten minute 
intervals. Significant increases in blood flow (up to 20 
times the control) were demonstrated by the iontophoresis of 
ABMC. The 2 controls (ABMC immersion without current and 
iontophoresis of saline solution) experienced no significant 
changes in blood flow. Parameters very similar to these were 
used by Abramson et a1 61 with the exception of decreased 
current-time dosages (5-15rnA for 10-20min). This study 
included tests on the forearm (n=17), leg (n=8) , and foot 
(n=5). It was demonstrated that the increased blood flow 
during ABMC iontophoresis returned to near baseline after an 
average of 33-58 minutes post-treatment. The study also 
showed that the vasodilatation which occurred during 
iontophoresis was primarily in the superficial/cutaneous 
circulation rather than in the deeper vessels. 
Abramson et a1 47 conducted a study on 16 subjects to 
determine the effect which histamine iontophoresis has on 
blood flow and blood oxygen content. Blood flow was measured 
with a segment type venous occlusion plethysmograph, and 
blood oxygenation was measured by the manometric method. The 
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oxygen uptake was calculated using the Fick principle. The 
histamine diphosphate solution (0.0001%) was transferred 
using 140-300 rnA-min iontophoresis. The results of this 
experiment show a significant increase in blood flow during 
treatment which continued for approximately 65 minutes after 
the iontophoresis ended. In 93% of the experiments, 
calculated oxygen uptake fell during early treatment. While 
60% of these remained below the baseline throughout 
treatment, 40% rose back to baseline or above. The authors 
offered several possible explanations for this occurrence. 
Hyperhidrosis is a condition in which the individual 
experiences excessive, abnormal sweating of the hands, feet, 
axilla and/or trunk. 62 Shrivastava and Singh63 researched the 
use of tap water iontophoresis in hyperhidrosis. Thirty 
subjects with plantar and palmar hyperhidrosis completed 
this study. The 30 subjects were divided into three groups, 
each with two subgroups . Group 1 received iontophoresis with 
both electrodes in the same pan, and one subgroup received a 
dosage of 400 rnA-min compared to 625 rnA-min for the 
remaining sUbjects. In group 2 the electrodes were not 
placed in the same pan, and treatment time varied providing 
a dosage of 150 rnA-min for one subgroup and 250 rnA-min for 
the other. Treatment dosage for group 3 varied from 150-400 
rnA-min depending on the subjects tolerance. Water level In 
all treatments was adjusted to just cover the palmar or 
plantar surface. Anhidrosis was experienced by all 30 
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subjects. Variation in treatment dosage did not demonstrate 
significant increased benefits (P>0.05), but the number of 
treatments required for anhydrosis was significantly less 
(P<O.Ol) when electrodes were place in separate pans. Mean 
duration of anhydrosis was 5.86 months, but this varied from 
subject to subject and treatment group to group. 
Other researchers 64 ,65 have demonstrated that tap water 
iontophoresis provided only short term benefits, and was 
not as effective as using an anticholinergic solution. Grice 
et a1 64 compared the iontophoresis of tap water to a poldine 
methosulphate (PMS) solution (.05%-.075% solution) in the 
treatment of palmar, plantar, and axillary hyperhidrosis. 
Method of current delivery was similar to that used by 
Shrivastava and Sing63 , but subjects with axillary 
hyperhidrosis were treated with a gauze covered electrode 
soaked in the chosen solution. Iontophoresis was 
administered weekly for six to eight weeks. The dosage for 
the hands and feet was 15-20 rnA-min and 10-15 rnA-min for the 
axilla. Nine subjects received PMS iontophoresis while the 
other received tap water iontophoresis. In each subject, one 
side of the body received iontophoresis while the other did 
not, thus providing a control. 
Neither tap water nor PMS provided adequate control of 
axillary hyperhidrosis. While PMS provided quicker and 
generally a longer duration of anhidrosis, neither treatment 
provided long term relief. These authors agree with Morgan66 
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in that there is a possibility for a systemic effect and 
side-effect when using anticholinergic solutions. Table 1 
summarizes research studies on iontophoresis . 
Table 1. Substances Delivered by Iontophoresis 
Substance Polarit~,b 
Acetlc ACld NEG 
Acyclovir pas 










































Inflammation, myofascial syndromes 
arthritis, TMJ 
Hyperhidrosis 
Ear chondritis, antibiotic 
Ulcers, blood flow 
Absorption enhancement, edema, scleroderma, 
lymphedema 
Arthritis, tendinitis, myositis, bursitis, 
chronic pain, TMJ 
Herpes simplex 
Sclerotic, fibrosis, adhesions, 
scar tissue, trigger finger 
Inflammation,Skin anesthesia, 
TMJ, pain, arthritis 
Gouty tophi 
Muscle relaxant, vasodilator, pain, 
inflammatory conditions 
Vasodilator, ulcers, arthritis, ischemia 
edema 
Infected burn wounds, antibiotic 
Hyperhidrosis 
Analgesic, scar tissue,adhesive joints, 
pain, inflammation, edema 
Chronic osteomyelitis, bactericidal, ulcers 
Herpes simplex 




Asepsis, ulcers, dermatitis, wound healing 
a NEG 
b pas 
Negatively Charged Substances 



































Iontophoretic procedures as used in physical therapy 
related conditions have been explored. Numerous studies 
concentrated on decreasing pain and increasing ROM in 
various pathological conditions. Several relatively 
objective studies on primarily acute pain indicate favorable 
results, but other research is not in total agreement. The 
relief of chronic pain is well documented and supported by 
various researchers, but the effects may be only short term. 
Iontophoresis use by physical therapists to assist in tissue 
repair is not new. Conditions commonly treated include 
ulcers, burns, HSV lesions, and fungal infections. 
Iontophoresis has also been used as a bactericidal agents. 
Research supports the use of iontophoresis in treating 
neurotrophic and venous stasis ulcers. Iontophoresis has 
also been used in an attempt to control edema, increase 
blood flow, and decrease sweat production. While most 
research indicated favorable results, the effects were not 
always found to be long term. 
Repeated research on a single condition, with a 
specific drug, were rather limited. In my opinion, the 
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majority of these studies were non scientific, with no 
control groups. Most studies did not include specific 
treatment guidelines. Although the studies contained 
clinically applicable information, most of them were unable 
to demonstrate any level of cause and effect. 
From this independent study I have formulated two 
recommendations. First, that clinicians continue to perform 
research while striving to conduct it in a more scientific 
manner. This is needed to provide proof of efficiency to 
those who are currently requiring it. Second, I would 
recommend that therapist utilizing iontophoresis do so In an 
informed manner. The decision to use iontophoresis should be 
based on an experimental foundation considered specifically 
for the ion and pathological condition in question. 
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